Amphastar Pharmaceuticals, Inc. (AMPH)
22.55
+0.54
(+2.45%)
USD |
NASDAQ |
Aug 31, 16:00
22.55
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Operations (Annual) : 156.12M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 156.12M |
| December 31, 2024 | 213.39M |
| December 31, 2023 | 183.50M |
| December 31, 2022 | 88.77M |
| December 31, 2021 | 97.99M |
| December 31, 2020 | 57.27M |
| December 31, 2019 | 41.76M |
| December 31, 2018 | 38.19M |
| Date | Value |
|---|---|
| December 31, 2017 | 39.21M |
| December 31, 2016 | 38.56M |
| December 31, 2015 | 10.68M |
| December 31, 2014 | 21.05M |
| December 31, 2013 | 31.04M |
| December 31, 2012 | -1.65M |
| December 31, 2011 | 19.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viatris, Inc. | 2.316B |
| Supernus Pharmaceuticals, Inc. | 47.33M |
| Liquidia Corp. | -35.69M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |